Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New bleeding treatment tested in Kids' heart surgery

NCT ID NCT04376762

First seen Mar 21, 2026 · Last updated Jun 22, 2026 · Updated 17 times

Summary

This study compared two treatments for bleeding after heart surgery in children aged 2 years or younger. One group received a purified fibrinogen concentrate, the other received cryoprecipitate (a blood product). The goal was to see if the concentrate works as well as cryoprecipitate to reduce the need for blood transfusions. The trial included 31 children and will help plan a larger study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEEDING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Virginia Health System

    Charlottesville, Virginia, 22908, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Fibrinogen concentrate (Fibryga) and cryoprecipitate

What this could lead to

If it works, this could offer a safer, more standardized option to control bleeding in young children after heart surgery.

What could go wrong

This is a small pilot study with only 31 children, so results may not apply to all patients. The trial is not designed to prove superiority, only to guide a larger study.

Conditions

The condition(s) this trial relates to.

Hemorrhage hemorrhagic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.